The focus of our upcoming research, therefore, will be to gain a better understanding of the relationship between WFDC2 and the insulin-like growth factor pathway to ascertain the role of WFDC2 on the physiological and pathological behavior of ovarian cancer. This evidence concerns the gene WFDC2 and ovarian carcinoma.